Background and Objectives: Febrile neutropenia (FN) is considered a medical emergency.
Patients with hematological malignancies (HM) commonly experience FN. Broad spectrum …

Objective of the present study was to describe the profile of infections in febrile neutropenia
(FN) in acute leukemia and hematopoietic stem cell transplant (HSCT) with emphasis on …

Background. Febrile neutropenia is the consequence of treatment of hematological
disorders. The first‐line empirical treatment should cover the prevalent microorganism of the …

BACKGROUND: Febrile neutropenia (FN) is a common but serious complication of
chemotherapy in patients with solid tumors (ST) and hematological malignancies (HM). The …

There is paucity of information from eastern India with regard to observed dominant micro-
organisms causing febrile neutropenia (FN) in patients with haematological malignancies …

Background The epidemiology of Gram-negative bacteria in patients with febrile
neutropenia (FN) and their susceptibility to initial empirical antibiotic therapy is key to …

Objective: Febrile neutropenia (FN) is one of the most serious clinical problems in patients
with hematologic malignancies and patients receiving chemotherapy. The present study was …

Background: The aim of this study was to study clinical profile with bacterial spectrum and
susceptibility patterns of pathogens in culture positive febrile neutropenic (FN) patients of …

Introduction: Febrile neutropenia (FN) remains a major cause of morbidity and mortality in
Oncology/Haematology units. We launched a new protocol for FN management that …

Objective: Febrile neutropenic episodes (FNEs) are among the major causes of mortality in
patients with hematological malignancies. Secondary infections develop either during the …